Desq Long
Sign in

Company

OptimizeRx Corp

OPRX · CIK 0001448431

SEC FORM 4
$11,255.52

OptimizeRx Corp (OPRX)

Disposition (code F) of 1,432 shares at $7.86 per share.

Reporting Person D'Silva Andrew J. · Officer Title Chief Business Officer · Transaction Code F

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001628280-26-060059 · filed 2026-09-02 · View filing →

SEC FORM 4
$10,647.51

OptimizeRx Corp (OPRX)

Disposition (code F) of 1,381 shares at $7.71 per share.

Reporting Person Stelmakh Edward · Officer Title Chief Finance & Strat Officer · Transaction Code F

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001628280-26-058583 · filed 2026-08-24 · View filing →

SEC FORM 4
$9,583.53

OptimizeRx Corp (OPRX)

Disposition (code F) of 1,243 shares at $7.71 per share.

Reporting Person D'Silva Andrew J. · Officer Title Chief Business Officer · Transaction Code F

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001628280-26-058584 · filed 2026-08-24 · View filing →

SEC FORM 4
$11,788.59

OptimizeRx Corp (OPRX)

Disposition (code F) of 1,529 shares at $7.71 per share.

Reporting Person Odence-Ford Marion · Officer Title Chief Legal & Admin Officer · Transaction Code F

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001628280-26-058586 · filed 2026-08-24 · View filing →

SEC FORM 4
$13,392.27

OptimizeRx Corp (OPRX)

Disposition (code F) of 1,737 shares at $7.71 per share.

Reporting Person Silvestro Stephen L · Officer Title Chief Executive Officer · Transaction Code F

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001628280-26-058588 · filed 2026-08-24 · View filing →

SEC FORM 4
$7,864.20

OptimizeRx Corp (OPRX)

Disposition (code F) of 1,020 shares at $7.71 per share.

Reporting Person Merrell Brendan W. · Officer Title CHIEF OPERATING OFFICER · Transaction Code F

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001628280-26-058589 · filed 2026-08-24 · View filing →

SEC FORM 4
$0.00

OptimizeRx Corp (OPRX)

Acquisition (code A) of 57,600 shares at $0 per share.

Reporting Person Odence-Ford Marion · Officer Title Chief Legal & Admin Officer · Transaction Code A

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001628280-26-058669 · filed 2026-08-24 · View filing →

SEC FORM 4
$0.00

OptimizeRx Corp (OPRX)

Acquisition (code A) of 57,600 shares at $0 per share.

Reporting Person Merrell Brendan W. · Officer Title CHIEF OPERATING OFFICER · Transaction Code A

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001628280-26-058670 · filed 2026-08-24 · View filing →

SEC FORM 4
$0.00

OptimizeRx Corp (OPRX)

Acquisition (code A) of 57,600 shares at $0 per share.

Reporting Person D'Silva Andrew J. · Officer Title Chief Business Officer · Transaction Code A

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001628280-26-058672 · filed 2026-08-24 · View filing →

SEC FORM 4
$0.00

OptimizeRx Corp (OPRX)

Acquisition (code A) of 79,200 shares at $0 per share.

Reporting Person Silvestro Stephen L · Officer Title Chief Executive Officer · Transaction Code A

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001628280-26-058673 · filed 2026-08-24 · View filing →